REFERENCES
- Shrader SK, Band JD, Lauter CB, et al. The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis. 1990;162:115–120.
- Leibovitch I, Lai T, Raymond G, et al. Endogenous endophthalmitis: a 13-year review at a tertiary hospital in South Australia. Scand J Infect Dis. 2005;37:184–189.
- Jackson TL, Eykyn SJ, Graham EM, et al. Endogenous bacterial endophthalmitis: A 17-y prospective series and review of 267 reported cases. Surv Ophthalmol. 2003;48:403–423.
- Okada AA, Johnson RP, Liles WC, et al. Endogenous bacterial endophthalmitis: report of a ten-year retrospective study. Ophthalmology. 1994;101:832–838.
- Binder MI, Chua J, Kaiser PK, et al. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine. 2003;82:97–105.
- Kostick DA, Foster RE, Lowder CY, et al. Endogenous endophthalmitis caused by Candida albicans in a healthy woman. Am J Ophthalmol. 1992;113:593–595.
- Valluri S, Moorthy RS, Liggett PE, et al. Endogenous Aspergillus endophthalmitis in an immunocompetent individual. Int Ophthalmol. 1993;17:131–135.
- Michelson JB, Friedlander MH. Endophthalmitis of drug abuse. Int Ophthalmol Clin. 1987;27:120–126.
- Weishaar PD, Flynn HW Jr, Murray TG, et al. Endogenous Aspergillus endophthalmitis: clinical features and treatment outcomes. Ophthalmology. 1998;105:57–65.
- Wong JS, Chan TK, Lee HM, et al. Endogenous bacterial endophthalmitis: an East Asian experience and a reappraisal of a severe ocular affliction. Ophthalmology. 2000;107:1483–1491.
- Schiedler V, Scott IU, Flynn HW Jr, et al. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol. 2004;137:725–731.
- Krishna R, Amuh D, Lowder CY, et al. Should all patients with candidemia have an ophthalmic examination to rule out ocular candidiasis? Eye. 2000;14:30–34.
- Rao NA, Hidayat AA. Endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosis. Am J Ophthalmol. 2001;132:244–51.
- Lundquist O, Osterlin S. Glucose concentration in the vitreous of nondiabetic and diabetic human eyes. Graefes Arch Clin Exp Ophthalmol. 1994;232:71–74.
- DiMattio J, Zadunaisky JA, Altszuler N. Onset of changes in glucose transport across ocular barriers in streptozotocin-induced diabetes. Invest Ophthalmol Vis Sci. 1984;25:820–826.
- Tanaka M, Kobayashi Y, Takebayashi H, et al. Analysis of predisposing clinical and laboratory findings for the development of endogenous fungal endophthalmitis. Retina. 2001;21:203–209.
- Essman TF, Flynn HW Jr, Smiddy WE, et al. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers. 1997;28:185–194.
- Chen YJ, Kuo HK, Wu PC, et al. A 10-y comparison of endogenous endophthalmitis outcomes: an East Asian experience with Klebsiella pneumonia infection. Retina. 2004;24:383–390.
- Shammas HF. Endogenous E. coli endophthalmitis. Surv Ophthalmol. 1977;21:429–435.
- Barza M. Factors affecting the intraocular penetration of antibiotics. Scand J Infect Dis. (Suppl) 1978;14:151–159.
- Louria DB, Dineen P. Amphotericin B in the treatment of disseminated moniliasis. JAMA. 1960;174:273–275.
- Green WR, Bennett JE, Goos RD. Ocular penetration of amphotericin B: a report of laboratory studies and a case report of post-surgical cephalosporium endophthalmitis. Arch Ophthalmol. 1965;73:769.
- Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis. 1990;12:308–329.
- Souri EN, Green R. Intravitreal amphotericin B toxicity. Am J Ophthalmol. 1974;78:77–81.
- Savani DV, Perfect JR, Cobo LM. Penetration of new azole compounds in the eye and efficacy in experimental Candida endophthalmitis. Antimicrobiol Agents Chemother. 1987;31:6–10.
- Akler ME, Vellend H, McNeely DM, et al. Use of fluconazole in the treatment of candidal endophthalmitis. Clin Infect Dis. 1995;20: 657–664.
- Christmas N, Smiddy W. Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers. 1996;27:1012–1018.
- Luttrull J, Wan WL, Kuback B, et al. Treatment of ocular fungal infections with oral fluconazole. Am J Ophthalmol. 1995;119:477–481.
- Romero CF, Rai MK, Lowder CY, et al. Endogenous endophthalmitis: case report and brief review. Am Fam Physician. 1999;60:510–514.
- Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479–1496.